Bicara Therapeutics
formerly BicaraIPOFighting cancer with precision and power.
Public · Cambridge, United States · Founded 2020 · $313.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- bicaratherapeutics.com
- Total Funding
- $313.0M
- Last Round
- $165.0M Series CDec 2023
- Rounds
- 3
- Type
- Public
About
Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class bifunctional biologics that combine tumor-targeting antibodies with tumor microenvironment modulators to treat solid tumors. Its bifunctional antibody platform is designed to deliver immunomodulatory payloads directly to the tumor site, enabling synergistic anti-tumor immune activity. The company is publicly traded (Nasdaq: BCAX) and advancing its lead programs through Phase 1b and Phase 3 clinical trials.
Summary
Bicara Therapeutics is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $313.0M in total across 3 rounds, most recently a $165.0M Series C round in Dec 2023. Investors include Red Tree Venture Capital, RA Capital Management and Biocon Limited.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Feb 2026
Sign up to see all 5 rounds
Seed through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
China's leading blood products manufacturer
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bicara-therapeutics"><img src="https://indexed.vc/api/badge/company/bicara-therapeutics" alt="Bicara Therapeutics on Indexed.vc" width="260" height="76" /></a>